Bioprocessing White Papers

1. Beyond Particle Counting: Why Modern Biologics Need Particle Forensics 4/8/2026

   High particle counts don’t always mean high risk. Identifying particle type and origin—not just quantity—avoids false alarms, protects timelines, and turns data into action.

2. Optimize Time, Space and Cost With Inline Buffer Formulation And System 4/7/2026

   Discover how integrating inline buffer formulation with chromatography reduces buffer waste by 50% and delivers a 710% ROI, transforming downstream efficiency and sustainability.

3. Flexibility In Drug Development: From Tactical Response To Strategic Imperative 4/6/2026

   Build flexibility into your drug development strategy to navigate change effectively, maintain momentum, and drive successful outcomes across every stage of the lifecycle.

4. Early-Phase Injectable Formulation Development 4/6/2026

   Discover how expert-driven strategies and data-centric tools can help you overcome formulation challenges and accelerate the development of stable, high-performance injectable therapeutics.

5. The Effect Of Conventional Cooling Versus Controlled Ice Nucleation On Primary Drying Time 4/1/2026

   See how controlled ice nucleation shortens lyophilization cycles, supports higher drying temperatures, and reduces complexity for amorphous and mixed formulations without sacrificing quality.

6. Biopharma Supply, Reimagined: Regional, Resilient Manufacturing 4/1/2026

   Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.

7. Mammalian Cell Line Development 3/26/2026

   Explores how modern cell line engineering boosts speed, stability, and scalability across biologics, with practical insights to cut risk and improve readiness for downstream development.

8. Systematic Strategy To Reduce The Cost Of Goods Sold 3/26/2026

   Learn key ways to cut biologics manufacturing costs through smarter process design, material choices, and supply resilience — driving more efficient, reliable, and commercially sustainable production.

9. Tool Enzymes For Antibody-Drug Conjugate Development And Manufacturing 3/26/2026

   See how modern tool enzymes enable cleaner, more consistent ADC conjugation, sharper analytics, and a smoother path from research to clinical development — practical guidance for manufacturing.

10. Criteria For Effective Bioprocess Scale-Up 3/25/2026

    Discover four essential bioprocess scale-up criteria and how each balances hydrodynamics, shear, and mass transfer across manufacturing scales.